UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 723

Sortiert nach

Molecular and Immunohistochemical Testing in Mesothelioma and Other Mesothelial Lesions

Archives of pathology & laboratory medicine (1976), 2024-05, Vol.148 (5), p.e77-e89

2024

Link zum Volltext

Verfügbarkeit prüfen

L1CAM expression in cystic mesothelial lesions: a comparison with adenomatoid tumours, well‐differentiated papillary mesothelial tumours and malignant mesotheliomas

Histopathology, 2021-08, Vol.79 (2), p.272-274

2021

Link zum Volltext

Verfügbarkeit prüfen

Intercellular interaction dictates cancer cell ferroptosis via NF2-YAP signalling

Nature (London), 2019-08, Vol.572 (7769), p.402-406

2019

Link zum Volltext

Verfügbarkeit prüfen

Analysis of expression of programmed cell death 1 ligand 1 (PD-L1) in malignant pleural mesothelioma (MPM)

PloS one, 2015-03, Vol.10 (3), p.e0121071-e0121071

2015

Link zum Volltext

Verfügbarkeit prüfen

Exploiting the folate receptor α in oncology

Nature reviews. Clinical oncology, 2020-06, Vol.17 (6), p.349-359

2020

Link zum Volltext

Verfügbarkeit prüfen

Tumor PD-L1 expression in malignant pleural and peritoneal mesothelioma by Dako PD-L1 22C3 pharmDx and Dako PD-L1 28-8 pharmDx assays

Human pathology, 2019-05, Vol.87, p.11-17

2019

Link zum Volltext

Verfügbarkeit prüfen

Human CAR T cells with cell-intrinsic PD-1 checkpoint blockade resist tumor-mediated inhibition

The Journal of clinical investigation, 2016-08, Vol.126 (8), p.3130-3144

2016

Link zum Volltext

Verfügbarkeit prüfen

Novel insights into mesothelioma biology and implications for therapy

Nature reviews. Cancer, 2017-08, Vol.17 (8), p.475

2017

Link zum Volltext

Verfügbarkeit prüfen

Restoring expression of miR-16: a novel approach to therapy for malignant pleural mesothelioma

Annals of oncology, 2013-12, Vol.24 (12), p.3128-3135

2013

Link zum Volltext

Verfügbarkeit prüfen

Clinical and molecular validation of BAP1, MTAP, P53, and Merlin immunohistochemistry in diagnosis of pleural mesothelioma

Modern pathology, 2022-10, Vol.35 (10), p.1383-1397

2022

Link zum Volltext

Verfügbarkeit prüfen

Multifactorial T-cell Hypofunction That Is Reversible Can Limit the Efficacy of Chimeric Antigen Receptor―Transduced Human T cells in Solid Tumors

Clinical cancer research, 2014-08, Vol.20 (16), p.4262-4273

2014

Link zum Volltext

Verfügbarkeit prüfen

Statin suppresses Hippo pathway-inactivated malignant mesothelioma cells and blocks the YAP/CD44 growth stimulatory axis

Cancer letters, 2017-01, Vol.385, p.215-224

2017

Link zum Volltext

Verfügbarkeit prüfen

Intracavitary ‘T4 immunotherapy’ of malignant mesothelioma using pan-ErbB re-targeted CAR T-cells

Cancer letters, 2017-05, Vol.393, p.52-59

2017

Link zum Volltext

Verfügbarkeit prüfen

Metabolic rewiring and redox alterations in malignant pleural mesothelioma

British journal of cancer, 2020-01, Vol.122 (1), p.52-61

2020

Link zum Volltext

Verfügbarkeit prüfen

Exosomal transfer of miR-126 promotes the anti-tumour response in malignant mesothelioma: Role of miR-126 in cancer-stroma communication

Cancer letters, 2019-10, Vol.463, p.27-36

2019

Link zum Volltext

Verfügbarkeit prüfen

MicroRNA-215-5p Treatment Suppresses Mesothelioma Progression via the MDM2-p53-Signaling Axis

Molecular therapy, 2019-09, Vol.27 (9), p.1665-1680

2019

Link zum Volltext

Verfügbarkeit prüfen

Germline Mutation of Bap1 Accelerates Development of Asbestos-Induced Malignant Mesothelioma

Cancer research (Chicago, Ill.), 2014-08, Vol.74 (16), p.4388-4397

2014

Link zum Volltext

Verfügbarkeit prüfen

BAP1 is a novel regulator of HIF-1α

Proceedings of the National Academy of Sciences - PNAS, 2023-01, Vol.120 (4), p.e2217840120

2023

Link zum Volltext

Verfügbarkeit prüfen

Aberrant Pax-8 expression in well-differentiated papillary mesothelioma and malignant mesothelioma of the peritoneum: a clinicopathologic study

Human pathology, 2018-02, Vol.72, p.160-166

2018

Link zum Volltext

Verfügbarkeit prüfen

BAP1 Status Determines the Sensitivity of Malignant Mesothelioma Cells to Gemcitabine Treatment

International journal of molecular sciences, 2019-01, Vol.20 (2), p.429

2019

Link zum Volltext

Verfügbarkeit prüfen

Tumor-Derived GM-CSF Promotes Granulocyte Immunosuppression in Mesothelioma Patients

Clinical cancer research, 2018-06, Vol.24 (12), p.2859-2872

2018

Link zum Volltext

Verfügbarkeit prüfen

A Selective ALDH1A3 Inhibitor Impairs Mesothelioma 3-D Multicellular Spheroid Growth and Neutrophil Recruitment

International journal of molecular sciences, 2023-04, Vol.24 (7), p.6689

2023

Link zum Volltext

Verfügbarkeit prüfen

The carcinogenic effect of various multi-walled carbon nanotubes (MWCNTs) after intraperitoneal injection in rats

Particle and fibre toxicology, 2014-11, Vol.11 (1), p.59-59, Article 59

2014

Link zum Volltext

Verfügbarkeit prüfen

How asbestos drives the tissue towards tumors: YAP activation, macrophage and mesothelial precursor recruitment, RNA editing, and somatic mutations

Oncogene, 2018-05, Vol.37 (20), p.2645-2659

2018

Link zum Volltext

Verfügbarkeit prüfen

Overexpression of miR‐199/214 is a distinctive feature of iron‐induced and asbestos‐induced sarcomatoid mesothelioma in rats

Cancer science, 2020-06, Vol.111 (6), p.2016-2027

2020

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 723

Suche als RSS-Feed

Aktive Filter

PublikationsformNewsletter-Artikel

ThemaTumors

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(695)
Mit Volltextzugriff
(700)

Publikationsform

Artikel
(723)

Sprache

Englisch
(723)
Japanisch
(190)
Norwegisch
(1)

Erscheinungsjahr

n.n

Thema

14 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

Plos One
(68)
International Journal Of Molecular Sciences
(30)
Lung Cancer
(29)
Oncogene
(27)
Oncology Reports
(24)
British Journal Of Cancer
(21)
Cancer Science
(20)
International Journal Of Cancer
(20)
Anticancer Research
(18)
Modern Pathology
(18)

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)
... seit 90 Tagen
(3)

Menü

Weitere Dienste

Einstellungen

Molecular and Immunohistochemical Testing in Mesothelioma and Other Mesothelial Lesions

L1CAM expression in cystic mesothelial lesions: a comparison with adenomatoid tumours, well‐differentiated papillary mesothelial tumours and malignant mesotheliomas

Intercellular interaction dictates cancer cell ferroptosis via NF2-YAP signalling

Analysis of expression of programmed cell death 1 ligand 1 (PD-L1) in malignant pleural mesothelioma (MPM)

Exploiting the folate receptor α in oncology

Tumor PD-L1 expression in malignant pleural and peritoneal mesothelioma by Dako PD-L1 22C3 pharmDx and Dako PD-L1 28-8 pharmDx assays

Human CAR T cells with cell-intrinsic PD-1 checkpoint blockade resist tumor-mediated inhibition

Novel insights into mesothelioma biology and implications for therapy

Restoring expression of miR-16: a novel approach to therapy for malignant pleural mesothelioma

Clinical and molecular validation of BAP1, MTAP, P53, and Merlin immunohistochemistry in diagnosis of pleural mesothelioma

Multifactorial T-cell Hypofunction That Is Reversible Can Limit the Efficacy of Chimeric Antigen Receptor―Transduced Human T cells in Solid Tumors

Statin suppresses Hippo pathway-inactivated malignant mesothelioma cells and blocks the YAP/CD44 growth stimulatory axis

Intracavitary ‘T4 immunotherapy’ of malignant mesothelioma using pan-ErbB re-targeted CAR T-cells

Metabolic rewiring and redox alterations in malignant pleural mesothelioma

Exosomal transfer of miR-126 promotes the anti-tumour response in malignant mesothelioma: Role of miR-126 in cancer-stroma communication

MicroRNA-215-5p Treatment Suppresses Mesothelioma Progression via the MDM2-p53-Signaling Axis

Germline Mutation of Bap1 Accelerates Development of Asbestos-Induced Malignant Mesothelioma

BAP1 is a novel regulator of HIF-1α

Aberrant Pax-8 expression in well-differentiated papillary mesothelioma and malignant mesothelioma of the peritoneum: a clinicopathologic study

BAP1 Status Determines the Sensitivity of Malignant Mesothelioma Cells to Gemcitabine Treatment

Tumor-Derived GM-CSF Promotes Granulocyte Immunosuppression in Mesothelioma Patients

A Selective ALDH1A3 Inhibitor Impairs Mesothelioma 3-D Multicellular Spheroid Growth and Neutrophil Recruitment

The carcinogenic effect of various multi-walled carbon nanotubes (MWCNTs) after intraperitoneal injection in rats

How asbestos drives the tissue towards tumors: YAP activation, macrophage and mesothelial precursor recruitment, RNA editing, and somatic mutations

Overexpression of miR‐199/214 is a distinctive feature of iron‐induced and asbestos‐induced sarcomatoid mesothelioma in rats

Aktive Filter

Suchergebnisse filtern